DK1150981T3 - Terapeutisk necleosidforbindelse - Google Patents

Terapeutisk necleosidforbindelse

Info

Publication number
DK1150981T3
DK1150981T3 DK00902768T DK00902768T DK1150981T3 DK 1150981 T3 DK1150981 T3 DK 1150981T3 DK 00902768 T DK00902768 T DK 00902768T DK 00902768 T DK00902768 T DK 00902768T DK 1150981 T3 DK1150981 T3 DK 1150981T3
Authority
DK
Denmark
Prior art keywords
necleoside
therapeutic
compound
purin
cyclopentene
Prior art date
Application number
DK00902768T
Other languages
Danish (da)
English (en)
Inventor
Susan Mary Daluge
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK1150981T3 publication Critical patent/DK1150981T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00902768T 1999-02-12 2000-02-11 Terapeutisk necleosidforbindelse DK1150981T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9903091.8A GB9903091D0 (en) 1999-02-12 1999-02-12 Therapeutic nucleoside compound
PCT/GB2000/000429 WO2000047581A1 (fr) 1999-02-12 2000-02-11 Compose therapeutique a base de nucleoside

Publications (1)

Publication Number Publication Date
DK1150981T3 true DK1150981T3 (da) 2003-07-21

Family

ID=10847550

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00902768T DK1150981T3 (da) 1999-02-12 2000-02-11 Terapeutisk necleosidforbindelse

Country Status (14)

Country Link
US (1) US6630477B1 (fr)
EP (1) EP1150981B1 (fr)
JP (1) JP2002536448A (fr)
KR (1) KR20010102081A (fr)
CN (1) CN1346356A (fr)
AT (1) ATE237616T1 (fr)
AU (1) AU2450900A (fr)
DE (1) DE60002172T2 (fr)
DK (1) DK1150981T3 (fr)
ES (1) ES2195861T3 (fr)
GB (1) GB9903091D0 (fr)
HK (1) HK1039935B (fr)
PT (1) PT1150981E (fr)
WO (1) WO2000047581A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2368580A1 (fr) * 2006-06-21 2011-09-28 Ge Healthcare As Stabilisation de précurseurs de fluorothymidine
US11583497B2 (en) 2017-11-14 2023-02-21 The Schepens Eye Research Institute, Inc. Nano-emulsion of CBFß-RUNX1 inhibitor for ocular drug delivery

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229531B (it) * 1988-01-20 1991-09-04 Univ Minnesota Composti nucleosidi dideossidideidrocarbociclici e formulazione farmaceutica che li contiene
US4916224A (en) * 1988-01-20 1990-04-10 Regents Of The University Of Minnesota Dideoxycarbocyclic nucleosides
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
DE68907013D1 (de) * 1988-10-24 1993-07-15 Wellcome Found Guaninderivate mit antiviraler wirkung und deren pharmazeutisch vertraegliche salze.
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
EP0468119A1 (fr) * 1990-07-24 1992-01-29 Merrell Dow Pharmaceuticals Inc. Nouveaux analogues carbocycliques de certains nucléosides
JPH06199812A (ja) * 1991-02-12 1994-07-19 Takeda Chem Ind Ltd 新規シクロペンテン誘導体
GB9417249D0 (en) * 1994-08-26 1994-10-19 Wellcome Found A novel salt

Also Published As

Publication number Publication date
ES2195861T3 (es) 2003-12-16
WO2000047581A1 (fr) 2000-08-17
EP1150981B1 (fr) 2003-04-16
ATE237616T1 (de) 2003-05-15
GB9903091D0 (en) 1999-03-31
DE60002172T2 (de) 2003-11-27
CN1346356A (zh) 2002-04-24
KR20010102081A (ko) 2001-11-15
HK1039935B (zh) 2003-12-19
PT1150981E (pt) 2003-08-29
AU2450900A (en) 2000-08-29
US6630477B1 (en) 2003-10-07
DE60002172D1 (de) 2003-05-22
JP2002536448A (ja) 2002-10-29
HK1039935A1 (en) 2002-05-17
EP1150981A1 (fr) 2001-11-07

Similar Documents

Publication Publication Date Title
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
CY1105818T1 (el) Χρησεις του et743 στην θepαπευτικη αγωγη του καρκινου
MXPA03008623A (es) Combinacion farmaceutica para el tratamiento del cancer.
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
MY124091A (en) Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
ES2160707T3 (es) Composiciones que comprenden agentes deteriorantes del adn y p53.
NO20032027D0 (no) Effektive antitumorbehandlinger
MY138883A (en) Use of asiatic acid for treatment of cencer
HK1068606A1 (en) Novel aminobenzoephenones
DE59813162D1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
ATE357912T1 (de) Intrakorporelle medikamente zur hoch- energetischen phototherapeutischen behandlung von krankheiten
MD990258A (en) Method of treatment of the acute viral hepatitis B
EP1525216A4 (fr) Therapie combinee pour le traitement d'infection vih
EA200200853A1 (ru) Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака
MY124071A (en) Treatment of viral disease in swine
NZ512850A (en) Treatment of papillomavirus infections
DK1251850T3 (da) Anvendelse af et kombinationspræparat i cancerbehandling
DK1150981T3 (da) Terapeutisk necleosidforbindelse
AU2002234644A1 (en) Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases
ATE371446T1 (de) Zusammensetzungen zur verhinderung der adhäsion
EP1143981A4 (fr) Traitement et prevention d'infections par le vih et d'autres infections virales
TR200000728T2 (tr) Kronik hepatit C' nin tedavisinde IFN-alfa ve amantadin kullanımı.
WO2003059334A3 (fr) Gemcitabine pour traiter la variole
RU99122488A (ru) Способ лечения рака эндометрия
UA34333A (uk) Спосіб лікування тяжких форм флюорозу зубів